It is my understanding that for the present the desensitization program has been shelved by Glaxo due to a data base review by the FDA which revealed problems with severe hypersensitivity in several patients who restarted abacavir even though they had limited signs or symptoms of hypersensitivity when they stopped it. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither The Body nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material. Questions and messages posted to this forum are not statements of advice,opinion, or information of The Body, Body Health Resources Corporation or any sponsor of this forum. While neither The Body nor Body Health Resources Corporation regularly reviews posted content, we reserve the right to delete, move, or edit postings if we deem it appropriate under the circumstances.
Visitors submitting questions remain solely responsible for the content of their messages.
Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as legal or other professional advice. This information is not a substitute for professional advice or care. If you have or suspect you may have a health or legal problem, you should consult your own health care provider or your attorney. Copyright notice .